Aurinia Presents Data Reinforcing LUPKYNIS® Safety and

Aurinia Presents Data Reinforcing LUPKYNIS® Safety and Efficacy for People with Lupus Nephritis at Congress of Clinical Rheumatology East 2024

Aurinia Presents Data Reinforcing LUPKYNIS® Safety and Efficacy for People with Lupus Nephritis at Congress of Clinical Rheumatology East 2024

eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Maryland , Rockville , Gabriel Contreras , Ernie Yap , Matt Truman , Neil Solomons , Andrea Christopher , Kenneth Kalunian , Matthewg Baker , Greg Keenan , Maria Dallera , Anca Askanase , Lucys Hodge , Aurinia Pharmaceuticals Inc , Nasdaq , European Commission , Drug Administration , Clinical Program , Corporate Communications Investor Relations , Aurinia Pharmaceuticals , Clinical Rheumatology , Aspreva Lupus Management Study , Chief Medical Officer , Propensity Analysis , Maria Dall Era , Long Term Safety , Black Patients , Red Cell Aplasia , Drug Interactions , Prescribing Information , Boxed Warning , Medication Guide , Clinical Rheumatology East , Investor Inquiries , Business Wire ,